This Week’s CGT News: In Vivo CAR T Draws Major Investment

Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes

• August 10, 2026

• 4 min

• The Medicine Maker